News | August 04, 2022
Sandu Pharmaceuticals launches Sandu Kumarvin
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029
Subscribe To Our Newsletter & Stay Updated
